Finance

Lists
OMED:IDX
Jayamas Medica Industri TBK PT
IDR 228.00
-0.87%
(-2.00) 1D
Oct 14, 4:09:33 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OMED...
Open
IDR 232
High
IDR 232
Low
IDR 224
Mkt. cap
6.17T
Avg. vol.
24.78M
Volume
13.52M
Dividend
1.79%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 18, 2026
P/E ratio
14.25
52-wk high
IDR 318
52-wk low
IDR 180
EPS
IDR 16
Shares outstanding
27.06B
No. of employees
1K
Open
IDR 232
High
IDR 232
Low
IDR 224
Mkt. cap
6.17T
Avg. vol.
24.78M
Volume
13.52M
Dividend
1.79%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 18, 2026
P/E ratio
14.25
52-wk high
IDR 318
52-wk low
IDR 180
EPS
IDR 16
Shares outstanding
27.06B
No. of employees
1K
News stories
From web sources and news partners
About Jayamas Medica Industri TBK PT
CEO-
Employees1.34K
Founded2000
Headquarters-
SectorMedical device
Websiteonemed.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
544.05B
593.92B
572.25B
594.55B
Cost of goods sold
360.63B
371.43B
367.36B
381.50B
Cost of revenue
360.63B
371.43B
367.36B
381.50B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
81.93B
94.61B
92.93B
94.87B
Operating expense
82.90B
98.16B
92.93B
94.70B
Total operating expenses
443.53B
469.59B
460.29B
476.20B
Operating income
100.52B
124.33B
111.96B
118.34B
Other non operating income
-144.67M
-180.05M
-2.58B
-194.78M
EBT including unusual items
125.06B
136.64B
127.20B
153.35B
EBT excluding unusual items
123.21B
138.72B
127.29B
153.35B
Income tax expense
23.97B
23.47B
28.24B
30.82B
Effective tax rate
19.17%
17.18%
22.20%
20.10%
Other operating expenses
942.91M
3.63B
-
-
Net income
100.48B
112.74B
98.37B
121.07B
Net profit margin
18.47%
18.98%
17.19%
20.36%
Earnings per share
-
-
-
-
Interest and investment income
15.64B
16.38B
15.27B
15.03B
Interest expense
-3.75B
-6.31B
-5.07B
-5.16B
Net interest expenses
11.89B
10.07B
10.20B
9.86B
Depreciation and amortization charges
-
-
-
-
EBITDA
114.87B
140.74B
124.88B
131.52B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps